Nexalin Technology, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:NXL)

Financials

Cash from operating activities -1.13 M-1.43 M-917.16 K-1.47 M-1.15 M-1.71 M -5.24 M Cash from investing activities 1.63 M1.47 M-3.92 M1.63 M689.18 K1.51 M -96.07 K Cash from financing activities 0—00523.55 K756.42 K — Free cash flow -1.13 M-1.43 M-931.84 K-1.48 M-1.16 M-1.78 M -5.35 M

News

EXCLUSIVE: Nexalin Study Flags Reduced Self-Injury In Adolescents Using Brain Stimulation Device - Nexali

EXCLUSIVE: Penny Stock Nexalin Advances Pivotal Trial Aiming To Tackle Severe Insomnia - Nexalin Technology (NASDAQ:NXL)

Nuix 1H26 presentation: Neo platform surges 148%, cash flow turns positive

Earnings call transcript: Nuix Ltd reports strong H1 2026 growth amid Neo platform expansion

Nexalin Technology stock rises after launching AI-powered virtual clinic

EXCLUSIVE: Nexalin Launches AI-Powered Virtual Clinic For Brain Health For Home Settings - Nexalin Technology (NASDAQ:NXL)

Nexalin reports brain imaging studies validate its neurostimulation tech

Nexalin receives Nasdaq minimum bid price deficiency notice

Nexalin advances Alzheimer’s device after FDA meeting

Nexalin Technology earnings missed by $0.01, revenue fell short of estimates

Nexalin signs exclusive distribution deal for neurostimulation device in Israel

FDA accepts Nexalin’s submission for Alzheimer’s treatment device